We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Trastuzumab
Australian Public Assessment Report
Device/Product Name
Ogivri
Active ingredients
Trastuzumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2017-01084-1-4
Submission Type
Biosimilar
Decision
Approved